Detalhe da pesquisa
1.
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma.
Blood
; 141(25): 3055-3064, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001036
2.
Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements.
Eur J Nucl Med Mol Imaging
; 49(3): 943-952, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476551
3.
Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial.
Eur J Nucl Med Mol Imaging
; 48(2): 509-520, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32789599
4.
Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial.
World J Urol
; 39(7): 2439-2446, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079250
5.
Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer.
Eur J Nucl Med Mol Imaging
; 47(10): 2481, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535653
6.
[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer.
Eur J Nucl Med Mol Imaging
; 47(4): 849-859, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31705176
7.
Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer.
Eur J Nucl Med Mol Imaging
; 46(7): 1495-1505, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30798428
8.
Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer.
Eur J Nucl Med Mol Imaging
; 46(9): 1911-1918, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31230088
9.
Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis.
Eur J Nucl Med Mol Imaging
; 45(6): 951-961, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29362858
10.
Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment.
Eur J Nucl Med Mol Imaging
; 45(13): 2307-2317, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30094460
11.
Clinical value of 18 FDG PET/CT in screening for distant metastases in head and neck squamous cell carcinoma.
Clin Otolaryngol
; 43(3): 875-881, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29377508
12.
Prediction of disease-free survival using relative change in FDG-uptake early during neoadjuvant chemoradiotherapy for potentially curable esophageal cancer: A prospective cohort study.
Dis Esophagus
; 30(2): 1-7, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27001344
13.
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial.
Ann Oncol
; 27(4): 619-24, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26598545
14.
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.
Br J Cancer
; 111(4): 749-55, 2014 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24983372
15.
Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.
Br J Cancer
; 109(9): 2445-52, 2013 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24104968
16.
Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.
Ann Surg Oncol
; 20(9): 3098-105, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23612885
17.
Reply: Should we assess repeatability of PET quantitative uptake measurements of each 18F-labelled tracer?
Eur J Nucl Med Mol Imaging
; 45(7): 1274-1275, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29654344
18.
Prognostic value of the standardized uptake value for (18)F-fluorodeoxyglucose in patients with stage IIIB melanoma.
Eur J Nucl Med Mol Imaging
; 39(10): 1592-8, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22801730
19.
Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 22(6): 382-392, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953740
20.
First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging.
Ann Oncol
; 22(3): 559-566, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20702788